Research ArticleExperimental Studies
MLH1 Is a Prognostic Biomarker for Serous Ovarian Cancer Treated With Platinum- and Taxane-based Chemotherapy
NAOYUKI KAWASHIMA, HIROYUKI YOSHIDA, MAIKO MIWA and KEIICHI FUJIWARA
Anticancer Research October 2019, 39 (10) 5505-5513; DOI: https://doi.org/10.21873/anticanres.13743